(Q37390251)

20 August 2017

1 reference

title

Multidrug-resistant to extensively drug resistant tuberculosis: what is next? (English)

1 reference

20 August 2017

0 references

multiple drug resistance

1 reference

1

Amita Jain

1 reference

20 August 2017

Pratima Dixit

2

1 reference

20 August 2017

language of work or name

1 reference

1 November 2008

1 reference

20 August 2017

published in

Journal of Biosciences

1 reference

20 August 2017

volume

33

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

605-616

1 reference

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12038-008-0078-8

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-008-0078-8

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-008-0078-8

Extensively drug-resistant Mycobacterium tuberculosis, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-008-0078-8

Multidrug-resistant tuberculosis management in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-008-0078-8

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-008-0078-8

Rational 'DOTS plus' for the control of MDR-TB.

21 January 2018

1 reference

12 December 2020

Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century

1 reference

12 December 2020

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

1 reference

12 December 2020

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

1 reference

12 December 2020

The nature and consequence of genetic variability within Mycobacterium tuberculosis

1 reference

12 December 2020

Comparing genomes within the species Mycobacterium tuberculosis

1 reference

12 December 2020

The treatment of multidrug-resistant tuberculosis in Turkey

1 reference

12 December 2020

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

1 reference

12 December 2020

Drug-resistant tuberculosis in Africa

1 reference

12 December 2020

The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium

1 reference

12 December 2020

A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK

1 reference

12 December 2020

Prospects for development of new antituberculous drugs

1 reference

12 December 2020

Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India?

1 reference

12 December 2020

Increasing transparency in partnerships for health--introducing the Green Light Committee

1 reference

12 December 2020

Current medical treatment for tuberculosis

1 reference

12 December 2020

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

12 December 2020

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

12 December 2020

Factors associated with drug resistance in pulmonary tuberculosis.

1 reference

12 December 2020

A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB).

1 reference

12 December 2020

Involving private health care providers in delivery of TB care: global strategy

1 reference

12 December 2020

Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study

1 reference

12 December 2020

Scientific basis of directly observed treatment, short-course (DOTS)

1 reference

12 December 2020

Programmes and principles in treatment of multidrug-resistant tuberculosis

1 reference

12 December 2020

Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.

1 reference

12 December 2020

Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.

1 reference

12 December 2020

Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?

1 reference

12 December 2020

Costs of patients hospitalized for multidrug-resistant tuberculosis.

1 reference

12 December 2020

Epidemiology of HIV-TB in Asia.

1 reference

12 December 2020

Multidrug-resistant tuberculosis.

1 reference

12 December 2020

Can DOTS control multidrug-resistant tuberculosis?

1 reference

12 December 2020

Does DOTS work in populations with drug-resistant tuberculosis?

1 reference

12 December 2020

Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment

1 reference

12 December 2020

Cost effectiveness analysis of strategies for tuberculosis control in developing countries

1 reference

12 December 2020

Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement.

1 reference

12 December 2020

Health-systems efficiency in the Russian Federation: tuberculosis control.

1 reference

12 December 2020

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

1 reference

12 December 2020

Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control

1 reference

12 December 2020

Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran

1 reference

12 December 2020

Antituberculosis drug resistance in the south of Vietnam: prevalence and trends

1 reference

12 December 2020

International standards for tuberculosis care

1 reference

12 December 2020

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1 reference

12 December 2020

Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control

1 reference

12 December 2020

Development of antituberculous drugs: current status and future prospects

1 reference

12 December 2020

Southern Africa is moving swiftly to combat the threat of XDR-TB.

1 reference

12 December 2020

125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

1 reference

12 December 2020

Stopping tuberculosis proves hard to do

1 reference

12 December 2020

Worldwide emergence of extensively drug-resistant tuberculosis

1 reference

12 December 2020

Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.

1 reference

12 December 2020

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

1 reference

12 December 2020

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis

1 reference

12 December 2020

Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa

1 reference

12 December 2020

Multidrug resistant tuberculosis: what is the risk in france?

1 reference

12 December 2020

Extensively drug-resistant tuberculosis, Italy and Germany

1 reference

12 December 2020

High rate of extensively drug-resistant tuberculosis in Indian AIDS patients

1 reference

12 December 2020

Treatment of tuberculosis by private general practitioners in India

1 reference

12 December 2020

Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital

1 reference

12 December 2020

Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.

1 reference

12 December 2020

Antituberculosis drug resistance in south Texas.

1 reference

12 December 2020

Multiple-drug-resistant tuberculosis

1 reference

12 December 2020

Treatment of multidrug-resistant tuberculosis

1 reference

12 December 2020

Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.

1 reference

12 December 2020

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

12 December 2020

10.1007/S12038-008-0078-8

Identifiers

DOI

1 reference

release_h5sdgptkczgwzov5axm2wpnphu

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h5sdgptkczgwzov5axm2wpnphu

24 November 2022

mapped directly with Wikidata item

1 reference